Sign in
Taking people in United StatesNo phase

Studying How Gut Fermentation Affects Obesity and Insulin Resistance in Young People

Tests lactulose in young people with obesity to study gut fermentation and insulin resistance.

Key facts

Who runs it
Yale University
Where
New Haven, United StatesSee the site
Trial code
Registry title
New Mechanisms of Obesity
Status
Recruiting
People taking part
55 people, planned
Started
13 Nov 2025
Expected to end
31 Mar 2030
Type of study
Interventional, 2 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • Lactulose Oral Product
Record updated
28 January 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for young people aged 15 to 22 who have obesity and are in puberty. It studies how gut fermentation and insulin resistance affect metabolism.

Age
15 to 22 years
Sex
All sexes can join.
Disease stage
In puberty (Tanner stage III-V) and a BMI above the 85th percentile.
Earlier treatment
Cannot be taking medicines that affect insulin resistance, such as metformin or GLP-1 analogues.

Main reasons for not taking part

  • Pregnancy
  • Hormone gland diseases (e.g., Cushing syndrome)
  • Substance abuse
  • Medicines affecting insulin resistance, such as metformin or GLP-1 analogues
  • High fibre intake (more than 30g/day) on a 3-day food record

The registry criteria, word for word

Show all 8 criteriaShow less

Who can take part

  • Age 15 to 22 years
  • In puberty (girls and boys: Tanner stage III-V)
  • BMI >85th

Who cannot take part

  • medications affecting insulin resistance such as metformin, GLP-1 analogues; -
  • endocrinopathies (e.g., Cushing syndrome)
  • Pregnancy
  • substance abuse
  • high fibers intake (> 30g/day) as assessed by a 3-day food record

Check if you might fit

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 15 and 22 years old?

Where in United States

  • Yale UniversityNew Haven, United StatesContact: NICOLA SANTORO, MD, PhDTaking people

About the trial

What the trial wants to find out

Given the pervasiveness of Pediatric Obesity, it is imperative to understand its pathophysiology and develop alternative strategies to reverse this condition. Herein, investigators propose to elucidate the interaction between colonic fermentation and insulin resistance in modulating metabolism in youth with obesity.

The 2 groups in the trial

  • Remote physical exerciseTreatment being tested

    Treatment: Lactulose Oral Product

  • Control physical exerciseExisting treatment, for comparison

    Treatment: Lactulose Oral Product

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Saves a reminder to your own calendar to look at this page again. Frontlight sends no messages and does not know you set it.

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Pathogenic Mechanisms of Obesity and Its Cardiometabolic Complications
Plain-language title
Studying How Gut Fermentation Affects Obesity and Insulin Resistance in Young PeopleGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 12 November 2026.
Fit questions
Built from NCT06768827, who can take part
Record updated
28 January 2026